Shin J-H, Bostick B, Yue Y, Duan D: Duchenne cardiomyopathy gene therapy. Muscle gene therapy. Edited by: Duan D. 2010, New York: Springer Science + Business Media, LLC, 141-162.
Chapter
Google Scholar
Dunn JF, Radda GK: Total ion content of skeletal and cardiac muscle in the mdx mouse dystrophy: Ca2+ is elevated at all ages. J Neurol Sci. 1991, 103: 226-231. 10.1016/0022-510X(91)90168-7.
Article
CAS
PubMed
Google Scholar
Alloatti G, Gallo MP, Penna C, Levi RC: Properties of cardiac cells from dystrophic mouse. J Mol Cell Cardiol. 1995, 27: 1775-1779. 10.1016/S0022-2828(95)91019-0.
Article
CAS
PubMed
Google Scholar
Williams IA, Allen DG: Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol. 2007, 292: H846-855.
Article
CAS
PubMed
Google Scholar
Fauconnier J, Thireau J, Reiken S, Cassan C, Richard S, Matecki S, Marks AR, Lacampagne A: Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci USA. 2010, 107: 1559-1564. 10.1073/pnas.0908540107.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sarma S, Li N, van Oort RJ, Reynolds C, Skapura DG, Wehrens XH: Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy. Proc Natl Acad Sci USA. 2010, 107: 13165-13170. 10.1073/pnas.1004509107.
Article
PubMed Central
CAS
PubMed
Google Scholar
Frank KF, Bolck B, Erdmann E, Schwinger RH: Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res. 2003, 57: 20-27. 10.1016/S0008-6363(02)00694-6.
Article
CAS
PubMed
Google Scholar
Kawase Y, Hajjar RJ: The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases. Nat Clin Pract Cardiovasc Med. 2008, 5: 554-565. 10.1038/ncpcardio1301.
Article
CAS
PubMed
Google Scholar
Lipskaia L, Chemaly ER, Hadri L, Lompre AM, Hajjar RJ: Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure. Expert Opin Biol Ther. 2010, 10: 29-41. 10.1517/14712590903321462.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rohman MS, Emoto N, Takeshima Y, Yokoyama M, Matsuo M: Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts. Biochem Biophys Res Commun. 2003, 310: 228-235. 10.1016/j.bbrc.2003.09.005.
Article
CAS
PubMed
Google Scholar
Ghosh A, Yue Y, Shin J-H, Duan D: Systemic trans-splicing AAV delivery efficiently transduces the heart of adult mdx mouse, a model for Duchenne muscular dystrophy. Hum Gene Ther. 2009, 20: 1319-1328. 10.1089/hum.2009.058.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bostick B, Yue Y, Lai Y, Long C, Li D, Duan D: Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther. 2008, 19: 851-856. 10.1089/hum.2008.058.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bostick B, Shin J-H, Yue Y, Duan D: AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice. Mol Ther. 2011, online publication on August 2 2011. doi:10.1038/mt.2011.154,
Google Scholar
Bostick B, Yue Y, Duan D: Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve. 2010, 42: 600-603. 10.1002/mus.21763.
Article
PubMed Central
PubMed
Google Scholar
Bostick B, Yue Y, Long C, Duan D: Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression. Circ Res. 2008, 102: 121-130. 10.1161/CIRCRESAHA.107.162982.
Article
CAS
PubMed
Google Scholar
Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, Tsuji T, Takewa Y, del Monte F, Peluso R, Zsebo K, Jeong D, Park WJ, Kawase Y, Hajjar RJ: Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol. 2007, 42: 852-861. 10.1016/j.yjmcc.2007.01.003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, Tanguay JF, Hajjar RJ: Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol. 2008, 51: 1112-1119. 10.1016/j.jacc.2007.12.014.
Article
CAS
PubMed
Google Scholar
Hajjar RJ, Zsebo K, Deckelbaum L, Thompson C, Rudy J, Yaroshinsky A, Ly H, Kawase Y, Wagner K, Borow K, Jaski B, London B, Greenberg B, Pauly DF, Patten R, Starling R, Mancini D, Jessup M: Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail. 2008, 14: 355-367. 10.1016/j.cardfail.2008.02.005.
Article
CAS
PubMed
Google Scholar
Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ: Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail. 2009, 15: 171-181. 10.1016/j.cardfail.2009.01.013.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ghosh A, Yue Y, Long C, Bostick B, Duan D: Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol Ther. 2007, 15: 750-755.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bostick B, Ghosh A, Yue Y, Long C, Duan D: Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther. 2007, 14: 1605-1609. 10.1038/sj.gt.3303029.
Article
CAS
PubMed
Google Scholar
Lai Y, Yue Y, Liu M, Ghosh A, Engelhardt JF, Chamberlain JS, Duan D: Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol. 2005, 23: 1435-1439. 10.1038/nbt1153.
Article
PubMed Central
CAS
PubMed
Google Scholar
Xu Z, Yue Y, Lai Y, Ye C, Qiu J, Pintel DJ, Duan D: Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum Gene Ther. 2004, 15: 896-905.
Article
PubMed Central
CAS
PubMed
Google Scholar
Duan D, Yue Y, Zhou W, Labed B, Ritche TC, Grosschedl R, Engelhardt JF: Submucosal Gland Development in the Airway is Controlled by Lymphoid Enhancer Binding Factor-1 (Lef-1). Development. 1999, 126: 4441-4453.
CAS
PubMed
Google Scholar
Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D: Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther. 2009, 17: 253-261. 10.1038/mt.2008.264.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hadri L, Bobe R, Kawase Y, Ladage D, Ishikawa K, Atassi F, Lebeche D, Kranias EG, Leopold JA, Lompre AM, Lompré AM, Lipskaia L, Hajjar RJ: SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells. Mol Ther. 2010, 18: 1284-1292. 10.1038/mt.2010.77.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yue Y, Liu M, Duan D: C-terminal truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double knock-out mice. Mol Ther. 2006, 14: 79-87. 10.1016/j.ymthe.2006.01.007.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bostick B, Yue Y, Duan D: Phenotyping cardiac gene therapy in mice. Methods Mol Biol. 2011, 709: 91-104. 10.1007/978-1-61737-982-6_6.
Article
PubMed Central
CAS
PubMed
Google Scholar
Duan D: Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum Mol Genet. 2006, 15 (Spec No 2): R253-261.
Article
PubMed Central
CAS
PubMed
Google Scholar
Beeri R, Chaput M, Guerrero JL, Kawase Y, Yosefy C, Abedat S, Karakikes I, Morel C, Tisosky A, Sullivan S, Handschumacher MD, Gilon D, Vlahakes GJ, Hajjar RJ, Levine RA: Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circ Heart Fail. 2010, 3: 627-634. 10.1161/CIRCHEARTFAILURE.109.891184.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ: Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure. Circulation. 2011, 124: 304-313. 10.1161/CIRCULATIONAHA.111.022889.
Article
CAS
PubMed
Google Scholar
Divet A, Lompre AM, Huchet-Cadiou C: Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice. Acta Physiol Scand. 2005, 184: 173-186. 10.1111/j.1365-201X.2005.01450.x.
Article
CAS
PubMed
Google Scholar
Kaspar RW, Allen HD, Montanaro F: Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract. 2009, 21: 241-249. 10.1111/j.1745-7599.2009.00404.x.
Article
PubMed Central
PubMed
Google Scholar
Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D: Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart. Circulation. 2003, 108: 1626-1632. 10.1161/01.CIR.0000089371.11664.27.
Article
PubMed Central
CAS
PubMed
Google Scholar
Townsend D, Blankinship MJ, Allen JM, Gregorevic P, Chamberlain JS, Metzger JM: Systemic Administration of Micro-dystrophin Restores Cardiac Geometry and Prevents Dobutamine-induced Cardiac Pump Failure. Mol Ther. 2007, 15: 1086-1092.
CAS
PubMed
Google Scholar
Wu B, Moulton HM, Iversen PL, Jiang J, Li J, Spurney CF, Sali A, Guerron AD, Nagaraju K, Doran T, Lu P, Xiao X, Lu QL: Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc Natl Acad Sci USA. 2008, 105: 14814-14819. 10.1073/pnas.0805676105.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark KR, Li J, Xiao X, Samulski J, McPhee SW, Samulski RJ, Walker CM: Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med. 2010, 363: 1429-1437. 10.1056/NEJMoa1000228.
Article
PubMed Central
CAS
PubMed
Google Scholar
Constantin B, Sebille S, Cognard C: New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. J Muscle Res Cell Motil. 2006, 27: 375-386. 10.1007/s10974-006-9085-2.
Article
CAS
PubMed
Google Scholar
Allen DG, Gervasio OL, Yeung EW, Whitehead NP: Calcium and the damage pathways in muscular dystrophy. Can J Physiol Pharmacol. 2010, 88: 83-91. 10.1139/Y09-058.
Article
CAS
PubMed
Google Scholar
Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, Metzger JM: Dystrophic heart failure blocked by membrane sealant poloxamer. Nature. 2005, 436: 1025-1029. 10.1038/nature03844.
Article
CAS
PubMed
Google Scholar
Fanchaouy M, Polakova E, Jung C, Ogrodnik J, Shirokova N, Niggli E: Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium. 2009, 46: 114-121. 10.1016/j.ceca.2009.06.002.
Article
PubMed Central
CAS
PubMed
Google Scholar
Janssen PM, Hiranandani N, Mays TA, Rafael-Fortney JA: Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol. 2005, 289: H2373-2378. 10.1152/ajpheart.00448.2005.
Article
CAS
PubMed
Google Scholar
Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, Molkentin JD: Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest. 2011, 121: 1044-1052. 10.1172/JCI43844.
Article
PubMed Central
CAS
PubMed
Google Scholar